Nueva publicación del Grupo MICROBIO en la revista “Antibiotics” (Q1) de la editorial MDPI

  • Publicado por:
  • 29 diciembre 2022
  • Comentarios desactivados

Artículo original que lleva por título: “Olive leaf as a source of antibacterial compounds active against antibiotic-resistant strains of Campylobacter jejuni and Campylobacter coliAntibiotics202312 (1), 26.

Publicado en la revista de acceso libre Antibiotics (Q1, Factor de Impacto 5.222) de la editorial MDPI, dentro del número especial “Medicinal plants as a source of novel classes of antimicrobial agents” editado por el Dr. Satish N. Dighe (Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia).

ABSTRACT: Campylobacter spp. are the main cause of bacterial gastroenteritis worldwide, and broiler chicks are the main vector of transmission to humans. The high prevalence of Campylobacter in poultry meat and the increase of antibiotic resistant strains have raised the need to identify new antimicrobial agents. For this reason, the aim of the current study was to evaluate the antibacterial activity of two extracts of olive leaf against antibiotic-resistant Campylobacter strains (C. jejuni and C. coli) isolated from poultry food chain. The extracts of olive leaf (E1 and E2) were markedly different in their chemical compositions. While E1 was composed predominantly of highly hydrophilic compounds such as hydroxytyrosol and hydroxytyrosol glucosides (14,708 mg/100 g), E2 mainly contained moderately hydrophilic compounds, with oleuropein (20,471 mg/100 g) being prevalent. All Campylobacter strains exhibited similar antibiotic profiles, being resistant to ciprofloxacin and tetracycline. E1 showed strong antibacterial activity and reduced bacterial growth from 4.12 to 8.14 log CFU/mL, depending on the strain. Hydroxytyrosol was the main compound responsible, causing the inhibition of growth of Campylobacter strains at low concentrations (0.1–0.25 mg/mL). E2 demonstrated a lower antibacterial effect than E1, reducing growth from 0.52 to 2.49 log CFU/mL. The results of this study suggest that the optimization of the composition of olive-leaf extracts can provide improved treatment results against Campylobacter strains.

Categorías: Noticias, Publicaciones